This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Arcticzymes as, Universitetet I Tromsø—norges Arktiske Universitet, Biotec Pharmacon Asa. Active years: 2013-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
3 out of 15 
2 out of 21 
Years Active: 2013-2020
Title: Biography of Inventor Morten Elde
Introduction
Morten Elde is a notable inventor based in Tromsø, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of thermolabile exonucleases. With a total of five patents to his name, Elde's work has advanced the understanding and application of enzymatic processes in molecular biology.
Latest Patents
One of Morten Elde's latest patents focuses on thermolabile exonucleases. This invention provides an exonuclease or an enzymatically active fragment that is substantially irreversibly inactivated by heating at a temperature of about 55°C for 10 minutes in a specific buffer. The exonuclease is designed to be substantially specific for single-stranded DNA and exhibits 3'-5' exonuclease activity. The patent also outlines methods for removing single-stranded DNA from samples, nucleic acid amplification, reverse transcription, and nucleic acid sequence analysis using the exonuclease. Additionally, it includes nucleic acids encoding the exonuclease and kits or compositions comprising the same.
Career Highlights
Throughout his career, Morten Elde has worked with several prominent companies in the biotechnology sector, including Arcticzymes AS and Biotec Pharmacon ASA. His experience in these organizations has allowed him to collaborate on various innovative projects and contribute to advancements in enzymatic technologies.
Collaborations
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile